Abstract

To survey the effects of hysteroscopic surgery combined with hormone monitoring and hormone therapy on postoperative symptom improvement and prognosis of patients with functional uterine bleeding, and to analyse its safety. From November 2021 to March 2023, 94 patients with functional uterine bleeding treated in our hospital were arbitrarily assigned into observation group (n=47) and control group (n=47). On both groups, hysteroscopic endometrial resections were performed. Hormone monitoring and hormone therapy were given to the observation group, while no additional treatment was given to the control group. The therapeutic effects of both groups were carefully observed, including the time taken for clinical symptom improvement and the incidence of adverse reactions. Additionally, a comparison was made in terms of sex hormone levels, uterine-related parameters, serum indexes, and quality of life scores before and after treatment. After treatment, the levels of angiopoietin-2 and aquaporin 4 in both groups were lessened, and vascular endothelial growth factor was associated with the endothelial growth factor. After hysteroscopic surgery, hormone monitoring and hormone therapy have remarkable therapeutic effects on patients with functional uterine bleeding, which can remarkably lessen the time of clinical symptom improvement, regulate the level of sex hormones, improve serum indexes, and have few adverse reactions. This treatment program is worthy of clinical promotion.